Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature
Only some cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021 - February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 p...
Main Authors: | Stefano Veraldi, Vinicio Boneschi, Marco Cusini, Carlo Alberto Maronese |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-07-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/dr/article/view/9503 |
Similar Items
-
Giant pityriasis rosea
by: Zawar Vijay
Published: (2010-01-01) -
Domperidone‐induced pityriasis rosea‐like drug eruption
by: Sarra Saad, et al.
Published: (2022-04-01) -
Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman
by: Iman Al Hatmi, et al.
Published: (2023-11-01) -
Doxycycline In Pityriasis Rosea: Placebo- Controlled Clinical Trial
by: Ghassaq Al-Timimi, et al.
Published: (2007-04-01) -
Pityriasis rosea with erythema multiforme - like lesions: An observational analysis
by: Vineet Relhan, et al.
Published: (2013-01-01)